Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. (Q51595534)

7 April 2018

title

Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. (English)

1 reference

7 April 2018

main subject

pneumonia

0 references

Mycoplasma pneumoniae

object named as

Mycoplasma pneumoniae

1 reference

1 reference

7 April 2018

author name string

Bin Cao

series ordinal

1 reference

7 April 2018

Jiu-Xin Qu

series ordinal

1 reference

7 April 2018

Johan Van Eldere

series ordinal

1 reference

7 April 2018

publication date

14 September 2015

1 reference

7 April 2018

The Clinical Respiratory Journal

published in

1 reference

7 April 2018

volume

1 reference

7 April 2018

issue

1 reference

7 April 2018

page(s)

419-429

1 reference

7 April 2018

Burden of community-acquired pneumonia in North American adults

cites work

1 reference

Clinical and economic burden of community-acquired pneumonia among adults in Europe

21 January 2018

1 reference

Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network

21 January 2018

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

Guidelines for the management of adult lower respiratory tract infections--full version

21 January 2018

1 reference

Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population

21 January 2018

1 reference

Community-acquired pneumonia in children

21 January 2018

1 reference

Mycoplasma pneumoniae and its role as a human pathogen

21 January 2018

1 reference

Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections

21 January 2018

1 reference

Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China

21 January 2018

1 reference

Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia

21 January 2018

1 reference

Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China

21 January 2018

1 reference

High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

21 January 2018

1 reference

Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia.

21 January 2018

1 reference

Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae

21 January 2018

1 reference

The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness

21 January 2018

1 reference

Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

21 January 2018

1 reference

Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia

21 January 2018

1 reference

Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study

21 January 2018

1 reference

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children

21 January 2018

1 reference

Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections

21 January 2018

1 reference

Epidemiology and clinical features of Mycoplasma pneumoniae infection in children

21 January 2018

1 reference

Vaccine preventable community-acquired pneumonia in hospitalized children in Northwest China

21 January 2018

1 reference

Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan.

21 January 2018

1 reference

Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture

21 January 2018

1 reference

Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.

21 January 2018

1 reference

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan

21 January 2018

1 reference

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients

21 January 2018

1 reference

Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China

21 January 2018

1 reference

The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.

21 January 2018

1 reference

Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

21 January 2018

1 reference

Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012.

21 January 2018

1 reference

Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.

21 January 2018

1 reference

The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel

21 January 2018

1 reference

Management of macrolide-resistant Mycoplasma pneumoniae infection

21 January 2018

1 reference

First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain.

21 January 2018

1 reference

Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010

21 January 2018

1 reference

In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.

21 January 2018

1 reference

Antimicrobial drug use and resistance in Europe

21 January 2018

1 reference

Antibiotic prescribing practice for acute, uncomplicated respiratory tract infections in primary care settings in New Delhi, India

21 January 2018

1 reference

Prescription antibiotics for outpatients in Bangladesh: a cross-sectional health survey conducted in three cities

21 January 2018

1 reference

Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples.

21 January 2018

1 reference

Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.

21 January 2018

1 reference

Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands

21 January 2018

1 reference

Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis

21 January 2018

1 reference

Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China

21 January 2018

1 reference

Nested PCR-Linked Capillary Electrophoresis and Single-Strand Conformation Polymorphisms for Detection of Macrolide-Resistant Mycoplasma pneumoniae in Beijing, China

21 January 2018

1 reference

Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China

21 January 2018

1 reference

The use of macrolides in treatment of upper respiratory tract infections

21 January 2018

1 reference

Use and prescription of antibiotics in primary health care settings in China

21 January 2018

1 reference

Macrolide resistance in bacteremic pneumococcal disease: implications for patient management.

21 January 2018

1 reference

Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae

21 January 2018

1 reference

Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4

21 January 2018

1 reference

Epidemiology and characteristics of antimicrobial resistance in China

21 January 2018

1 reference

Changes in Chinese policies to promote the rational use of antibiotics

21 January 2018

1 reference

Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico

21 January 2018

1 reference

The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications.

21 January 2018

1 reference

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae

21 January 2018

1 reference

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients

21 January 2018

1 reference

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

21 January 2018

1 reference

Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia

21 January 2018

1 reference

Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

21 January 2018

1 reference

Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children

21 January 2018

1 reference

Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy

21 January 2018

1 reference

Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae

21 January 2018

1 reference

Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas

21 January 2018

1 reference

Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age

21 January 2018

1 reference

Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child.

21 January 2018

1 reference

Antimicrobial safety: focus on fluoroquinolones

21 January 2018

1 reference

Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders

21 January 2018

1 reference

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin

21 January 2018

1 reference

Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens

21 January 2018

1 reference

The Use of Systemic and Topical Fluoroquinolones

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CRJ.12379

1 reference

7 April 2018

1 reference

7 April 2018